TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,490,876 | -66.1% | 9,986,947 | +0.7% | 0.00% | -71.4% |
| Q2 2023 | $246,349,781 | +85.1% | 9,917,463 | +12.1% | 0.01% | +75.0% |
| Q1 2023 | $133,099,489 | +23.2% | 8,849,700 | -3.1% | 0.00% | +33.3% |
| Q4 2022 | $108,054,593 | +102.0% | 9,133,947 | +1.1% | 0.00% | +50.0% |
| Q3 2022 | $53,489,000 | +35.9% | 9,035,050 | -2.5% | 0.00% | +100.0% |
| Q2 2022 | $39,365,000 | -53.7% | 9,262,325 | +3.7% | 0.00% | -50.0% |
| Q1 2022 | $84,978,000 | -49.8% | 8,935,578 | +0.4% | 0.00% | -50.0% |
| Q4 2021 | $169,140,000 | -42.6% | 8,902,165 | +0.5% | 0.00% | -50.0% |
| Q3 2021 | $294,841,000 | -9.0% | 8,859,387 | +6.1% | 0.01% | -11.1% |
| Q2 2021 | $323,989,000 | -27.7% | 8,352,359 | -10.2% | 0.01% | -30.8% |
| Q1 2021 | $448,240,000 | +0.7% | 9,299,599 | +8.7% | 0.01% | -7.1% |
| Q4 2020 | $445,099,000 | +116.4% | 8,556,286 | +11.3% | 0.01% | +75.0% |
| Q3 2020 | $205,642,000 | +49.0% | 7,684,719 | +8.5% | 0.01% | +33.3% |
| Q2 2020 | $138,001,000 | +129.8% | 7,084,225 | +16.1% | 0.01% | +100.0% |
| Q1 2020 | $60,059,000 | -10.3% | 6,103,446 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $66,920,000 | +112.5% | 6,028,790 | +7.5% | 0.00% | +200.0% |
| Q3 2019 | $31,488,000 | -31.4% | 5,607,955 | +5.7% | 0.00% | -50.0% |
| Q2 2019 | $45,883,000 | +28.6% | 5,304,463 | +19.5% | 0.00% | 0.0% |
| Q1 2019 | $35,680,000 | +92.6% | 4,437,891 | -1.8% | 0.00% | +100.0% |
| Q4 2018 | $18,529,000 | -25.2% | 4,519,331 | +2.2% | 0.00% | 0.0% |
| Q3 2018 | $24,757,000 | -53.9% | 4,420,852 | +8.3% | 0.00% | -50.0% |
| Q2 2018 | $53,667,000 | +8.8% | 4,081,050 | +17.4% | 0.00% | 0.0% |
| Q1 2018 | $49,348,000 | +76.2% | 3,475,206 | +1.8% | 0.00% | +100.0% |
| Q4 2017 | $28,003,000 | -28.4% | 3,414,999 | +3.5% | 0.00% | -50.0% |
| Q3 2017 | $39,102,000 | +21.5% | 3,299,747 | +3.0% | 0.00% | 0.0% |
| Q2 2017 | $32,190,000 | +3.4% | 3,202,963 | +19.8% | 0.00% | 0.0% |
| Q1 2017 | $31,134,000 | +124436.0% | 2,672,508 | +50391.4% | 0.00% | – |
| Q4 2016 | $25,000 | -10.7% | 5,293 | +43.5% | 0.00% | – |
| Q3 2016 | $28,000 | +3.7% | 3,689 | -17.0% | 0.00% | – |
| Q2 2016 | $27,000 | -6.9% | 4,447 | +30.6% | 0.00% | – |
| Q1 2016 | $29,000 | -12.1% | 3,406 | +23.4% | 0.00% | – |
| Q4 2015 | $33,000 | +450.0% | 2,761 | +375.2% | 0.00% | – |
| Q3 2015 | $6,000 | -40.0% | 581 | 0.0% | 0.00% | – |
| Q2 2015 | $10,000 | -9.1% | 581 | -16.4% | 0.00% | – |
| Q1 2015 | $11,000 | +10.0% | 695 | +15.8% | 0.00% | – |
| Q4 2014 | $10,000 | +66.7% | 600 | 0.0% | 0.00% | – |
| Q3 2014 | $6,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q2 2014 | $6,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |